HomeSearchGlobal LocationsContact UsGenzyme Websites
About GenzymeOur ResearchOur ProductsOur Commitment
Genzyme

Corporate Info
Investors
News
Press Contacts
Press Kits
News Coverage
News Subscription
Genzyme Up Close
Partnering
Genzyme Events
Careers
Global Locations


Press Contacts

John Lacey
Associate Director, Corporate Communications
Phone: 617-768-6690
Corporate/executive issues; Financial results; Massachusetts issues; Public policy; Oncology (Campath, Clolar) and Alemtuzumab for MS.

Lori Gorski
Associate Director, Corporate Communications
Phone: 617-768-9344
Genetic diseases (Cerezyme, Fabrazyme, Aldurazyme, Myozyme); Transplant (Thymoglobulin, Mozobil); Biosurgery (Synvisc) and Corporate Social Responsibility.

Erin Emlock
Associate Manager, Corporate Communications
Phone: 617-768-6923
Renal disease (Renagel, Renvela, Hectorol); Endocrinology (Thyrogen); Cardiovascular disease (mipomersen); Diagnostics (point-of-care testing); Gene therapy; HR topics; Facilities and Environmental initiatives.

Sarah Millerick
Senior Corporate Communications Specialist
Phone: 617-768-6438
Genetics (reproductive and cancer testing); Cell therapies (Carticel and Epicel); Biosurgery (Seprafilm); and Community Relations.

Heidi De Wit
Director, Corporate Affairs Europe
International Issues
Phone: +32 2 714 17 42

Caroline De Bie
Corporate Communication Manager, Europe
European Issues
Phone: +32 2 714 17 45

If you would prefer to send an email please contact Media Relations.

If you are not a journalist and are calling with a general question about Genzyme, please call our main phone number:
617-252-7500.

Terms and Conditions of Use | Privacy Policy | © 2002-2009 Genzyme Corporation. All rights reserved.